ICPS PEARLS

Wednesday, November 12, 2025, 12:00 PM - Wednesday, November 11, 2026, 1:00 PM

The Midwest Medication Safety Symposium (M2S2) is an annual interdisciplinary regional event with a focus on improving medication safety practices and patient outcomes through education of pharmacists, pharmacy technicians, nurses, physicians, and the whole interprofessional health care team.

Launch Date: 11/12/2025

Expiration Date: 11/11/2026

A copy of the slides are available by reaching out to Jaida Speth at [email protected].

1. Recognize the importance of an interdisciplinary approach to medication safety.
2. Review opportunities to improve medication safety through the use of technology.
3. Explain medication safety strategies for frontline staff, students, new and experienced practitioners.

How to obtain CE credits:

Please note, you have to watch the entire video in order to receive any CE credit for this online activity.

Sign in or create a new account by clicking "Sign In" in top left corner. *If you previously participated in a CME activity accredited by IUSM  but do not know your password, please enter your email address and click on the 'Forget Your Password' link. Your password will be emailed to you.

1. Click the Tests tile > Launch Video to view the module.

2. After viewing the video go back to the Tests tile and click Post-Test to attest to completing the activity.

3. Click the MyCME button > Evaluations and Certificates

4. Find the activity name in the list and click Complete Evaluation.

5. Click Submit.

6. On the Evaluations and Certificates page, click Download Certificate or access your transcript through the Transcript tile.
   

Please note that you are not able to claim credit if you already attended the live virtual conference on October 17th, 2025.

In support of improving patient care, this activity has been planned and implemented by Indiana University School of Medicine and the Indianapolis Coalition for Patient Safety. Indiana University School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
Indiana University School of Medicine designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
Indiana University School of Medicine designates this activity for a maximum of 1.0 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists
Indiana University School of Medicine designates this activity for 1.0 ACPE contact hours. Pharmacists should only claim credit commensurate with the extent of their participation in the activity. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.

American Board of Surgery (ABS)
Successful completion of this CME activity enables the learner to earn credit toward the CME of the American Board of Surgery's Continuous Certification Program. It is the CME activity's provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit. 

References

US Food and Drug Administration (FDA) and Institute for Safe Medication Practices (ISMP). FDA and ISMP Lists of Look-Alike Drug Names with Recommended Tall Man Letters. ISMP; 2023.

Institute for Safe Medication Practices (ISMP). Implement strategies to prevent persistent medication errors and hazards. ISMP Medication Safety Alert! Acute Care. 2023;28(6):1-4.

Prograf (tacrolimus) [product monograph]. Markham, Ontario, Canada: Astellas Pharma Canada Inc; September 2024. Access on September 10, 2025.

Collin C, Boussaud V, Lefeuvre S, et al. Sublingual tacrolimus as an alternative to intravenous route in patients with thoracic transplant: a retrospective study. Transplant Proc. 2010;42(10):4331-4337.

Hanger, KM, Boettger RF, Watkins KD, et al. A Pharmacokinetic Analysis of Oral vs Sublingual Administration of Tacrolimus in Lung Transplant Recipients. CHEST, 2010; 138(4). 542A

Doligalski CT, Liu EC, Sammons CM, Silverman A, Logan AT. Sublingual administration of tacrolimus: current trends and available evidence. Pharmacotherapy. 2014;34(11):1209-1219.

Velleca A, Shullo MA, Dhital K, et al. The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2023;42(5):e1-e141.

Reams BD, Palmer SM. Sublingual tacrolimus for immunosuppression in lung transplantation: a potentially important therapeutic option in cystic fibrosis. Am J Respir Med. 2002;1(2):91-98.

AIM Aerosol Inhalation Trainer and Starter Pack. Vitalograph. Accessed November 6, 2024. https://vitalograph.com/products/aim-aerosol-inhalation-monitor.

O’Toole, J., Krishnan, M., Riekert, K. et al. Understanding barriers to and strategies for medication adherence in COPD: a qualitative study. BMC Pulm Med 22, 98 (2022). Doi: 10.1186/s12890-022-01892-5

Infusion Nurses Society. Policies and Procedures for Infusion Therapy: Infusion Therapy: Acute Care. 7th Edition. 2024

Nickel, et al. Standard 65: Vasopressor Administration. In, Infusion Therapy Standards of Practice. 9th Edition. Infusion Nurses Society, 2024

Neckel, Barbara A. Peripheral Vasopressor Administration: A Risk/Benefit Analysis. Podium Presentation presented at the American Association of Critical Care Nurses National Teaching Institute, May 2025

A Clinical Review of Vasopressors in Emergency Medicine Stampfl M et al. J Emerg Med. 2024;67(1):e31-e41

Use and Outcomes of Peripheral Vasopressors in Early Sepsis-Induced Hypotension Across Michigan Hospitals: A Retrospective Cohort Study Munroe ES et al. CHEST. 2024;165(4):847-857

Adverse events associated with administration of vasopressor medications through a peripheral intravenous catheter: a systematic review and meta-analysis Owen VS et al. Crit Care. 2021;25:146.

Feasibility and Safety of Peripheral Intravenous Administration of Vasopressor Agents in Resource Limited Settings Padmanaban A et al. J Crit Care Med (Targu Mures). 2020;6(4):210-216.

Complication of vasopressor infusion though peripheral venous catheter: A systematic review and meta-analysis. Tran QK et al. Am J Emerg Med. 2020;38(11):2434-2443.

Safety of the Peripheral Administration of Vasopressor Agents. Lewis T et al. J Intensive Care Med. 2019;34(1):26-33

Safety of peripheral administration of vasopressor medications: A systematic review. Tian DH et al. Emerg Med Australas. 2020;32(2):220-227.

Safety of peripheral administration of phenylephrine in a neurologic intensive care unit: A pilot study Delgado T et al. J Crit Care. 2016;34:107-110

A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters. Loubani OM et al. J Crit Care. 2015;30(3):653.e9-17.

Safety of peripheral intravenous administration of vasoactive medication. Cardenas-Garcia J et al. J Hosp Med. 2015;10(9):581-585

Talking Prescription Labels | En-Vision America | United States https://www.envisionamerica.com/ Talking Labels | ScriptAbility.com | United States https://www.scriptability.com/

ASHP Guidelines on the Safe Use of Automated Dispensing Cabinets. Am J Health-System Pharm. 2022;79:e71-82

Guidelines for the Safe Use of Automated Dispensing Cabinets. Institute for Safe Medication Practices. 2019.

For questions about accessibility or to request accommodations please contact the IUSM CME office at 317-274-0104 or [email protected]. One week advance notice will allow us to provide seamless access. Please ensure to specify the accommodations you need in order to participate.

AMA PRA Category 1 Credits™ (1.00 hours), ABS CC (1.00 hours), ACPE Contact Hours (1.00 hours), ANCC Contact Hours (1.00 hours), Non-Physician Attendance (1.00 hours)

Mitigation of Relevant Financial Relationships

Indiana University School of Medicine, Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.